Sun, Y., Zhang, J., Yang, W., Wu, G., Zhong, X., Zhang, W., Liang, P., Li, B., Cui, C. (2025). Phase II study of trifluridine/tipiracil (TAS-102) plus irinotecan in combination with bevacizumab as a second‐line therapy for patients with metastatic colorectal cancer.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.4_suppl.155